» Articles » PMID: 11559104

Composition and Antimicrobial Activity of the Essential Oils of Two Origanum Species

Overview
Date 2001 Sep 18
PMID 11559104
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

The essential oils obtained from the aerial parts of Origanum scabrum and Origaum microphyllum, both endemic species in Greece, were analyzed by means of GC and GC-MS. Forty-eight constituents were identified, representing 98.59 and 98.66% of the oils, respectively. Carvacrol, terpinen-4-ol, linalool, sabinene, alpha-terpinene, and gamma-terpinene were found as the major components. Furthermore, both samples exhibited a very interesting antimicrobial profile after they were tested against six Gram-negative and -positive bacteria and three pathogenic fungi.

Citing Articles

Optimization of the Antibacterial Activity of a Three-Component Essential Oil Mixture from Moroccan , , and Using a Simplex-Centroid Design.

Elbouzidi A, Taibi M, El Hachlafi N, Haddou M, Jeddi M, Baraich A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861120 PMC: 11769045. DOI: 10.3390/ph18010057.


In Vitro Antioxidant and Antibacterial Activities of Ethyl Acetate Extracts of Leaves and Five Associated Endophytic Fungi.

Ghazi-Yaker A, Kraak B, Houbraken J, Nabti E, Cruz C, Saadoun N Microorganisms. 2025; 12(12.

PMID: 39770873 PMC: 11728511. DOI: 10.3390/microorganisms12122671.


In Vitro Antibacterial and Antibiofilm Activities of L. Ethanolic Leaf Extract on ATCC 29213.

Lao R, Yabes A, Tobias-Altura M, Panganiban L, Makalinao I Acta Med Philipp. 2024; 57(12):53-60.

PMID: 39429760 PMC: 11484527. DOI: 10.47895/amp.vi0.6412.


Antimicrobial Activity of (Former ) and Related to Recognized Antimicrobial Bioactive Compounds.

Ilieva Y, Zaharieva M, Najdenski H, Kroumov A Int J Mol Sci. 2024; 25(10).

PMID: 38791586 PMC: 11122404. DOI: 10.3390/ijms25105548.


Phytochemical Analysis, Biological Activities, and Molecular Docking Studies of Root Extracts from Species in Serbia.

Batinic P, Jovanovic A, Stojkovic D, Zengin G, Cvijetic I, Gasic U Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675478 PMC: 11054981. DOI: 10.3390/ph17040518.